Residual neuromuscular blockade in myotonic dystrophy: lessons unlearned and sugammadex

Anaesth Intensive Care. 2011 Jul;39(4):756-7; author reply 757.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Airway Obstruction / chemically induced
  • Anesthesia Recovery Period
  • Cholinesterase Inhibitors / therapeutic use
  • Evidence-Based Medicine
  • Female
  • Guidelines as Topic
  • Humans
  • Intubation, Intratracheal
  • Monitoring, Intraoperative
  • Monitoring, Physiologic
  • Muscarinic Antagonists / therapeutic use
  • Myotonic Dystrophy / complications*
  • Neuromuscular Blockade / adverse effects*
  • Neuromuscular Nondepolarizing Agents / adverse effects
  • Neuromuscular Nondepolarizing Agents / antagonists & inhibitors
  • Pregnancy
  • Sugammadex
  • Synaptic Transmission / drug effects
  • Young Adult
  • gamma-Cyclodextrins / adverse effects*

Substances

  • Cholinesterase Inhibitors
  • Muscarinic Antagonists
  • Neuromuscular Nondepolarizing Agents
  • gamma-Cyclodextrins
  • Sugammadex